drugset / Trial / NCT07628881

A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy Adults

NCT07628881

Phase 1 Recruiting 12 enrolled BeOne Medicines
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to evaluate whether blood levels of sonrotoclax after administration of a tablet for oral suspension are similar to those observed with the current sonrotoclax tablet. In addition, this study evaluates the effect of food on the absorption of sonrotoclax after administration of the tablet for oral suspension and the resulting blood levels of sonrotoclax.

Timeline

Start
2026-06-17
Primary completion
2026-09-27
Completion
2026-09-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Sonrotoclax Other / unclassified Oral

Indications

No indication recorded.